NovantigoEvergreen Funds & ELTIF Database

ELTIF · Private Equity · Domiciled in France

FPCI Capital Sante 3

Managed by Turenne Capital Partenaires SA, France. Product design, fees, liquidity terms and AuM development, tracked monthly by Novantigo.

Request free trialFor professional investors · approved within one business day · no credit card
494
Funds tracked
50
Data points per fund
163
Private Equity funds
Monthly
AuM updates

About this fund

FPCI Capital Sante 3 is a closed-end French vehicle managed by Turenne Capital Partenaires SA, formed in 2025 as an FCP under the FPCI regime in France and constituted as an ELTIF aligned with the ELTIF 2.0 framework. It is denominated in EUR and pursues a multi-strategy approach within private equity, with access limited to professional investors and distribution confined to its home market. The manager has set a fund size of , against which committed and deployed capital stood at as of 31 Aug 2026.

Because the structure is closed-end, capital is drawn against commitments rather than subscribed on a dealing calendar, and there is no standing redemption facility; investors are returned capital through realisations over the life of the fund, so the holding period is effectively the fund term. The vehicle carries a summary risk indicator of 6 and is classified Article 8 under SFDR, reflecting environmental or social characteristics promoted alongside its investment objective rather than a dedicated sustainable investment objective. Portfolio exposure is spread across the markets shown in , consistent with the domestic focus of its distribution scope.

Within Novantigo's coverage of 494 vehicles, the fund is one of 163 in private equity and one of 80 domiciled in France, narrowing to 32 that combine both characteristics. That cohort provides the reference set against which its size, vintage and risk classification can be read, with the earlier figures benchmarked on the same basis.

Included in the free trial

AuM history

12 readings on file

Unlock

Fees and costs

12 fee fields tracked

Unlock

Peer comparison

162 comparable funds in the database

Unlock

Market analytics

League tables, AuM development and exports across 494 funds

Unlock

Inside every full profile35 locked fields

Fees & costs

  • Entry fee
  • Redemption fee
  • Management fee (retail, low)
  • Management fee (retail, high)
  • Management fee (institutional, low)
  • Management fee (institutional, high)
  • Early-investor fee
  • Fee basis
  • Operating expenses
  • Distribution fee
  • Total cost ratio
  • Performance fee
  • Hurdle rate
  • High-water mark

Portfolio construction

  • Fund-of-funds share
  • Primaries share
  • Secondaries share
  • Directs share
  • Co-investments share
  • Liquidity pocket
  • Europe allocation
  • North America allocation
  • Asia-Pacific allocation
  • Latin America allocation
  • Rest-of-world allocation

Terms & scale

  • Latest AuM
  • Target size
  • Target IRR
  • Life span
  • Redemption gate
  • Lock-up penalty
  • Leverage limit
  • Leverage (AIFMD)
  • Share classes
  • Master-feeder setup

Key facts

Structure

Manager
Turenne Capital Partenaires SA
Fund type
ELTIF
ISIN
FR001400PKK5
Legal structure
FCP
Regulatory regime
FPCI
ELTIF version
ELTIF 2.0
Fund structure
Closed-End
Inception
06 Jun 2025
Base currency
EUR

Strategy

Asset class
Private Equity
Strategy
Multi-Strategy
Geographic focus
Europe

Access & distribution

Investor type
Professional
Distribution scope
Domestic
Distribution countries
France, Luxembourg
SFDR
Article 8
Risk indicator (SRI)
6 of 7
›Frequently asked questions
Who manages FPCI Capital Sante 3?
FPCI Capital Sante 3 is managed by Turenne Capital Partenaires SA, headquartered in France.
What is an ELTIF?
A European Long-Term Investment Fund is an EU vehicle that lets non-institutional investors access private market assets under the ELTIF regulation (this fund operates under ELTIF 2.0).

Sourced from prospectuses, KIDs, factsheets and regulatory registers. Data as of 31 Aug 2026.

Similar funds: Amundi CPR France Investissement · Amundi ETI Megatendances · Andera Multi Buy Out